KEY THERAP
GenericsKEY THERAP is a generic drug manufacturer focused on Respiratory, Dermatology. Key products include ZONTIVITY.
KEY THERAP's Key Drugs
KEY THERAP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
KEY THERAP's Recent FDA Approvals
New NDA/BLA approvals for KEY THERAP over the last two years — novel drugs only, excluding generics and label supplements.
KEY THERAP's Therapeutic Areas
KEY THERAP's approved drugs and pipeline span 2 therapeutic areas, led by Respiratory and Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
KEY THERAP's Top Competitors
KEY THERAP's closest competitors by therapeutic-area and drug-target overlap include Bayer, APOTHECON, and PHARMACIA AND UPJOHN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
KEY THERAP Pipeline Snapshot
Active clinical trials for KEY THERAP across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Respiratory pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling